海藻酸钠的疏水改性及释药性能研究

为了提高对疏水性药物的负载量和缓释作用,将海藻酸钠氧化后与十二胺反应使其进行疏水改性.对改性后聚合物结构进行了表征.研究了聚合物在水溶液及盐溶液中的粘度变化;将聚合物分散于NaCl/CaCl2的混合溶液中制备成凝胶微球,对药物布洛芬进行了包埋释放实验.结果表明,疏水改性后的海藻酸钠粘度增加,其凝胶微球对布洛芬负载量提高,具有较好的缓释作用.     

新型潜香类化合物N-(2,3-吡嗪二甲酰基)-丙氨酸甲酯热裂解气相色谱-质谱分析

采用在线热裂解-气相色谱-质谱联用技术(Py-GC-MS)分析了潜香吡嗪类化合物N-(2,3-吡嗪二甲酰基)-丙氨酸甲酯的热裂解行为。首先通过对2,3-吡嗪二羧酸酰胺化反应合成了新型目标化合物N-(2,3-吡嗪二甲酰基)-丙氨酸甲酯,其结构经X射线单晶衍射(XRD),1H NMR,13C NMR,IR和HR-MS证实,然后在空气氛围中,对目标化合物分别在300,600,900℃下进行热裂解,并通过GC-MS对其挥发性热裂解产物进行定性和半定量分析。结果表明:1裂解形成了包括具有香味特征的吡嗪类、大茴香醇和大茴香醛在内的裂解产物共48种。不同温度下挥发性热裂解产物的类型和相对含量不同,300℃和600℃时相对含量最高的均为乙酸,而900℃时相对含量最高的为吡嗪,且与300℃和600℃裂解条件相比所形成的吡嗪类衍生物种类较多,相对含量较高。2在具有香味特征的裂解产物中,大茴香醇的相对含量随温度升高而升高,而大茴香醛和苯甲醛的相对含量则呈现随着温度升高而降低的趋势。基于目标化合物的热裂解产物的定性及定量变化情况,初步探讨了该物质可能的裂解机理。     

在线热裂解/气相色谱-质谱分析3-吡啶甲酸茴香酯的热裂解产物

采用在线热裂解/气相色谱-质谱(Py/GC-MS)联用技术对3-吡啶甲酸茴香酯进行热裂解分析。通过酰氯化和酯化反应合成了新型目标化合物3-吡啶甲酸茴香酯,其分子式为C14H14NO3。目标化合物的结构经核磁氢谱(1H NMR)、核磁碳谱(13C NMR)、红外光谱(IR)和高分辨质谱(HRMS)进行确证,并通过热重-微热重-差示扫描量热(TG-DTG-DSC)分析方法对目标化合物的热稳定性进行分析。在空气氛围中,将目标化合物分别于300,600,900℃下进行热裂解,并通过气相色谱-质谱法对其挥发性热裂解产物进行定性和半定量分析。研究显示:目标化合物共经历了两次失重过程。第一次失重在129.9~158.9℃之间,失重2.3%;第二次失重在158.9~274.9℃之间,失重达90.1%,230.1℃时失重率最大。热裂解共产生44种产物,包括具有香味特征的大茴香醛、对甲基苯酚、松油醇、D-香茅醇、大茴香醚和茴香醚等化合物。其中裂解温度对裂解产物的种类和相对含量具有明显影响。300℃时α-二去氢菖蒲烯的相对含量最高,600,900℃时,相对含量最高的分别是大茴香醛和对甲基苯酚。苯甲醛、茴香醚和大茴香醚的相对含量随着温度的升高呈先增加后降低趋势;而对甲基苯酚含量则随着温度的升高而增加。根据主要裂解产物及其相对含量的变化,对目标化合物的裂解机理进行了初步探讨。     

海藻酸钠-乙酸乙烯酯均相接枝共聚物合成及性能评价

本文采用了均相接枝共聚的方法合成了疏水改性的海藻酸钠-乙酸乙烯酯共聚物(SA-g-PVAc)。使用红外光谱、元素分析、凝胶渗透色谱手段对产物接枝度、溶解性能、分子量进行了评价,并考察了相关性能的变化规律。     

天然等同物覆盆子酮的合成工艺研究

以天然大茴香醛和发酵丙酮为起始原料,通过Claisen-Schmidt反应、选择性加氢、脱甲基实验得到天然级覆盆子酮。通过单因素实验和正交实验研究了三步反应的较佳工艺条件为:第一步,在氢氧化钠的作用下,氢氧化钠、大茴香醛以及丙酮的投料比为0.28:1:3,40℃反应1.5 h;第二步,催化剂雷尼镍的用量为1%,氢气压力为0.3 MPa,30℃反应14 h;第三步,以48%的氢溴酸做为催化剂,冰醋酸为溶剂,130℃,反应4h,得到天然级覆盆子酮,总收率:75.75%(以大茴香醛计),含量:98.65%,香气纯正。通过熔点、IR和~1H NMR对最终产物进行了结构表征。此工艺的研究为类似结构不饱和酮的选择性加氢提供了实验依据,且产品总收率较高,成本低,适合工业化生产。     

纤维素/海藻酸钠复合气凝胶的表面功能化与仿生矿化

通过高碘酸钠和亚氯酸钠的2次氧化法,对纤维素/海藻酸钠复合气凝胶进行表面氧化改性,将纤维素和海藻酸钠表面C2和C3位置的羟基氧化为羧基,有效地提高了复合气凝胶的矿化能力。通过傅里叶红外光谱仪(FT-IR)、扫描电镜(SEM)、X射线衍射仪(XRD)、X射线光电子能谱仪(XPS)、体外细胞毒性测试等对羧基化改性前后在复合气凝胶支架上的沉积物进行表征。结果表明,改性后复合气凝胶表面的磷灰石形成速率更快,晶粒更小,沉积层更均匀;改性复合气凝胶表面的羧基具有更强的Ca2+结合能力,可以诱导Ca2+吸附在气凝胶表面,使矿化能力提高。同时,小鼠成纤维细胞实验表明,矿化后的复合气凝胶无毒性,可以促进细胞生长和分化,是性能良好的骨组织工程材料。     

磷钨酸铜绿色催化合成乙酰缩醛的研究

合成了磷钨酸铜并利用XRD、FT-IR和UV等对其结构进行了表征,结果表明其具有Keggin结构.在室温无溶剂条件下,考察了磷钨酸铜催化一系列醛和乙酸酐合成相应的乙酰缩醛的反应.结果表明,醛和乙酸酐的物质量比为1∶2,磷钨酸铜用量仅需占醛的0.5%(摩尔比)就能使反应在较短时间内完成,产物产率可达62%~96%.该催化剂在醛和酮同时存在时,可以选择性地与醛基发生反应.     

烷基化改性壳聚糖制备条件对酚类化合物吸附的影响

采用脂肪醛与壳聚糖反应生成Schiff's碱,再用NaBH4还原制备了N-烷基化壳聚糖衍生物. 用元素分析测定了其取代度. 考察了不同烷基化条件对庚醛改性壳聚糖取代度和吸附性能的影响. 结果表明,反应时间、醛/壳聚糖配比和反应温度等因素影响烷基化壳聚糖的取代度. 在n(醛)∶ n(壳聚糖)=4∶ 1、反应温度为100 ℃和反应时间为8 h条件下,庚醛改性壳聚糖的取代度趋于最大值,取代度的增加有利于改性壳聚糖对2,4-二氯酚的吸附. 不同链长脂肪醛改性壳聚糖对酚的吸附影响结果表明,随着烷基化链长的增加,改性壳聚糖产物对酚的吸附量增加,但链长超过7个C时,吸附量反而下降.庚醛改性壳聚糖的吸附效果最好.     

直接缩聚法海藻酸钠/乳酸低聚物接枝共聚物的合成及释药性能研究

通过直接缩聚法使乳酸与海藻酸钠接枝聚合,实现了对海藻酸钠的疏水改性。结果发现,疏水改性后的海藻酸钠水溶液中出现粒径为80~110nm的颗粒,说明海藻酸钠接枝改性成功。将改性后的海藻酸钠溶液滴入到氯化钙溶液中制备成直径1.5mm左右凝胶微球。以布洛芬为药物模型进行释放研究,结果表明,所得凝胶微球对药物的载药率和包封率较改性前得到提高,缓释效果增强。药物在弱碱性溶液中释放比较快,而在酸性环境中基本不释放。利用此特点,可将共聚物制备成药物载体,用于肠道内的控制释放。     

钙离子诱导的海藻酸钠/黄原胶凝胶化临界行为研究

研究了海藻酸钠/黄原胶混合体系的相行为及其对海藻酸钠-钙离子凝胶化临界行为的影响.当海藻酸钠浓度为0.5 wt%时,随着黄原胶的添加,混合体系出现相容、相分离及液晶3种不同的相行为.与纯黄原胶溶液相比,海藻酸钠/黄原胶混合溶液在更低的黄原胶浓度下开始形成液晶,这是由于混合体系中相分离的发生导致了黄原胶有效浓度升高.利用葡萄糖酸内酯(GDL)在线酸化Ca-EDTA,释放钙离子,研究了不同钙离子引入量时(f=[Ca2+]/[COO-])混合体系的黏弹性.Winter-Chambon分析发现临界凝胶点(f gel)随黄原胶浓度的增加而降低.当相分离发生时,临界凝胶点急剧降低,当液晶结构形成后,临界凝胶点呈现上升趋势.通过对比Winter-Chambon方法和临界凝胶点模量松弛法所测得的松弛临界指数(nw和nr),发现黄原胶的添加使海藻酸钠临界凝胶失去结构自相似性.相分离的发生导致临界凝胶结构排列更加致密,而液晶的出现使临界凝胶结构排列相对疏松.     

Hydrophobically modified alginate for extended release of pharmaceuticals

Hydrophobically modified alginate hydrogels have great potential in drug delivery as they are biologically compatible and cost efficient. While previous works have shown successful protein, and hydrophobic and hydrophilic drug delivery, little information regarding the relationship between crosslinker density and drug release rate is known. This paper investigates the impact of crosslinker density and hydrophobic degree of substitution within modified alginate gels and solutions on the release kinetics using model hydrophobic drug, sulindac. Near zero‐order release was obtained for an extended period of 5 days. Drug release rates decreased as the crosslinker density within both modified alginate hydrogels and solutions increased. Release data fit well to a simplified Fickian relationship, suggesting that the release mechanism is diffusion‐limited. These release characteristics also correlate with bulk rheological measurements, indicating a strong interrelationship between the mechanical properties and the drug release characteristics of the hydrogels.     

改性海藻酸钠聚集行为对电纺纳米纤维形貌的影响

以过硫酸钾(KPS)为引发剂, 采用双丙酮丙烯酰胺(DAA)对海藻酸钠(SA)进行改性, 制备了海藻酸钠-聚双丙酮丙烯酰胺两亲性共聚物(SA-PDAA). 将SA-PDAA与聚乙烯醇(PVA)复配, 并进行静电纺丝, 制得SA-PDAA/PVA电纺纳米纤维. 通过红外光谱、 差示扫描量热和荧光光谱表征了SA-PDAA的结构和性能, 通过黏度仪、 表面张力仪和电导率仪测试了SA-PDAA纺丝液的物理性能, 用扫描电子显微镜表征了SA-PDAA/PVA电纺纳米纤维的形貌, 考察了SA-PDAA/PVA电纺纳米纤维的释药性能. 结果表明, DAA接枝到SA分子链上, SA-PDAA的临界聚集浓度为0.072 g/L, SA-PDAA具有良好的两亲性, SA-PDAA/PVA电纺纳米纤维具有均一的形貌. 改性后的SA可以有效地减缓药物释放速度, 提高SA-PDAA/PVA电纺纳米纤维的缓释性能.     

Formulation and In Vitro Evaluation of Sustained Release Microspheres of Diltiazem Hydrochloride Prepared by Emulsification-Internal Gelation Method

The present work describes the formulation of alginate microspheres containing diltiazem hydrochloride by the emulsification-internal gelation method with the use of barium carbonate as a cross-linking agent. The effect of various factors (the concentration of alginate and barium chloride) on the drug loading efficiency and in vitro release were investigated. Fourier transform infrared microscopy (FTIR) and differential scanninig calorimetry (DSC) analysis confirmed the absence of any drug polymer interaction. X-ray diffraction (XRD) pattern showed that there is a decrease crystallinity of the drug. The in vitro drug release profile could be altered significantly by changing various processing parameters to give a controlled release of drug from microcapsules. The stability studies of drug-loaded microcapsules showed that the drug was stable at different storage conditions.     

Studies in the development of nateglinide loaded calcium alginate and chitosan coated calcium alginate beads

Nateglinide loaded alginate-chitosan beads were prepared by ionic gelation method for controlling the drug release by using various combinations of chitosan and Ca2+ as cation and alginate as anion. IR spectrometry, scanning electron microscopy, differential scanning calorimetry and X-ray powder diffractometry were used to investigate the physicochemical characteristics of the drug in the bead formulations. The calcium content in beads was determined by atomic absorption spectroscopy. The swelling ability of the beads in different media (pH 1.2, 4.5, 6.8) has been found to be dependent on the presence of polyelectrolyte complex of the beads and the pH of the media. The ability to release the Nateglinide was examined as a function of chitosan and calcium chloride content in the gelation medium. It is evident that the rate of drug release and its kinetics could be controlled by changing the chitosan and the calcium chloride concentrations. Calcium alginate beads released more than 95% of drug with in 8 h; whereas coated beads sustained the drug release and released only 75-80% of drug. The drug release mechanism analyzed indicates that the release follows either "anomalous transport" or "case-II transport".     

Novel mucoadhesive carriers based on alginate-acrylamide hydrogels for drug delivery

New mucoadhesive two-component carriers for drug delivery based on synthetic acrylamide/diethylacrylamide and natural alginate hydrogels have been synthesized. The introduction of sodium alginate into polyacrylamide/ poly(diethylacrylamide) gels, followed by their crosslinking with metal ions, significantly changed structure and properties of hydrogels, such as swelling degree, drug capacity and drug release rate in physiological solution. The structure of the gels was characterized by FTIR spectroscopy and scanning electron microscopy.     

肝靶向海藻酸钠载药纳米粒的细胞毒性研究

本研究将具有肝靶向性分子甘草次酸（GA）偶联在具有生物相容性和生物可降解性的天然高分子海藻酸钠（ALG）上,合成了甘草次酸改性的海藻酸钠（GA—ALG）;对广谱抗癌药物阿霉素（DOX）进行包封,制备了肝靶向载药纳米粒,并考察了GA—ALG载药纳米粒的体外释药性能和对肝癌细胞的抑制作用．利用核磁、红外和元素分析技术对GA—ALG结构和GA取代度进行了表征;对GA—ALG载药纳米粒的形貌、粒径、表面Zeta电位等进行了测定,结果显示纳米粒具有较规则球形结构,其水合粒径为（214±11）nm．GA—ALG载药纳米粒在模拟生理条件下（pH7．4）可持续释药长达20天;MTT结果显示GA-ALG载药纳米粒对7703肝癌细胞的具有明显的杀伤作用．     

Inorganic–organic hybrid alginate beads with LCST near human body temperature for sustained dual‐sensitive drug delivery

In order to obtain dual‐stimuli‐responsive (temperature/pH) alginate beads that exhibit LCST close to human body temperature for sustained drug release applications, poly (NIPAAm‐co‐AAm) hydrogel (with LCST 37.5°C) were selected and associated with calcium alginate to prepare inorganic–organic hybrid biomineralized polysaccharide alginate beads via a one‐step method in this paper. Scanning electron microscopy (SEM) and energy dispersive X‐ray spectrometer (EDS) results demonstrated that calcium phosphate could not only be found in the surface but also in the cross‐section of biomineralized polysaccharide beads. Both equilibrium swelling and indomethacin release behavior were found to be pH‐ and thermo‐responsive. In addition, indomethacin release profile could be sustained with a inorganic–organic hybrid membrane: the release amount reached 96% within 4 hr for the unmineralized beads, while a drug release of only 64% obtained after subjecting the biomineralized polysaccharide beads to the same treatment. These results indicate that the biomineralized polysaccharide membrane could prevent the permeability of the encapsulated drug and reduce the drug release rate effectively. The studied system has the potential to be used as an effective smart sustainable delivery system for biomedical applications. Copyright © 2008 John Wiley & Sons, Ltd.     

Ionically crosslinked alginate/carboxymethyl chitin beads for oral delivery of protein drugs

Complex beads composed of alginate and carboxymethyl chitin (CMCT) were prepared by dropping aqueous alginate-CMCT into an iron(III) solution. The structure and morphology of the beads were characterized by IR spectroscopy and scanning electron microscopy (SEM). IR confirmed electrostatic interactions between iron(III) and the carboxyl groups of alginate as well as CMCT, and the binding model was suggested as a three-dimensional structure. SEM revealed that CMCT had a porous morphology while alginate and their complex beads had a core-layer structure. The swelling behavior, encapsulation efficiency, and release behavior of bovine serum albumin (BSA) from the beads at different pHs were investigated. The BSA encapsulation efficiency was fairly high (>90%). It was found that CMCT disintegrated at pH 1.2 and alginate eroded at pH 7.4 while the complex beads could effectively retain BSA in acid (>85%) and reduce the BSA release at pH 7.4. The results suggested that the iron(III)-alginate-CMCT bead could be a suitable polymeric carrier for site-specific protein drug delivery in the intestine.     

Cytotoxicity of liver targeted drug-loaded alginate nanoparticles

In this study, novel liver targeted doxorubicin (DOX) loaded alginate (ALG) nanoparticles were prepared by CaCl₂ crosslinking method. Glycyrrhetinic acid (GA, a liver targeted molecule) modified alginate (GA-ALG) was synthesized in a heterogeneous system, and the structure of GA-ALG and the substitution degree of GA were analyzed by ¹H NMR, FT-IR and elemental analysis. The drug release profile under the simulated physiological condition and cytotoxicity experiments of drug-loaded GA-ALG nanoparticles were carried out in vitro. Transmission electron micrographs (TEM) and dynamic light scattering (DLS) analysis showed that drug-loaded GA-ALG nanoparticles have spherical shape structure with the mean hydrodynamic diameter around 214 ± 11 nm. The drug release was shown to last 20 days, and the MTT assay suggested that drug-loaded GA-ALG nanoparticles had a distinct killing effect on 7703 hepatocellular carcinoma cells.